Simple research view

ALGN · Align Technology, Inc.

$168.05 latest stored close

Detected setup watchlist_candidate

Watch · Quality 0/100

Switch to Advanced for indicator panels, raw grades, provenance, drawing tools, and full technical tables.

$ALGN

Align Technology, Inc.

Align Technology, Inc. is a large-cap Medical Specialties company in the Health Technology sector with a market cap of $12B.

Strong Sell · 29 Health Technology Medical Specialties stock Stage 1 · Basing Base 1 Data 54m ago

$168.05 latest close

← Back Join to Watchlist $ALGN Share card

Council read · 6 methods

Watch — evidence is building

0 buyable · 3 watch · 3 avoid. Review the observed passes and blockers before reading the chart.

Review six verdicts Inspect chart

Earnings-risk mode

Pre-earnings setup

Wednesday, July 29, 2026 Time not confirmed No sourced report session or clock time

Ordinary position sizing suppressed. Earnings are less than three full trading sessions away; treat the gap as event risk, not ordinary stop-distance risk.

Deterministic evidence

ALGN+0.62%

Sector proxy · XLV+0.51%

Broad market · SPY+0.02%

Same completed session window ending 2026-07-27. ALGN was +0.11 points vs XLV. +0.60 points vs SPY.

CatalystUnavailable Stock reactionPositive Sector reactionSupportive Opening surgeUnavailable Event riskEarnings-driven

Price bars, sourced event fields, and benchmark math only. This can adjust displayed short-term conviction; it does not change the stored scanner score or readiness.

AI interpretation (optional)

Ask a Legend to interpret the evidence only after reviewing the deterministic event timing and relative reaction.

Interpret this evidence AI output is commentary, not scanner evidence or a sizing recommendation.

Price $168.05 Jul 27 close

52W High $208.30 -19.3%

52W Low $122.00

Wks Since High 49w

Base Depth -41.4%

Base B1

SMA 50 $172.42

SMA 200 $165.82

Avg Vol 1,026,509

RS Rank 1

RS vs High -30.1%

RS Slope -2.9% ▼

Grp Rank #48/64

ADR% 4.0%

ATR(14) $6.52 (3.9%)

Rel Vol (today) 1.01×

Vol Pace N/A

U/D Vol 0.87

A/D Days 15A / 14D

A/D Rating B

VDU Bars 0/10 d

Earnings tmrw

$122.00

$208.30 53%

ALGN Chart

Interactive price, volume, RS, RSI, and MACD charts are available after sign in.

Create a free account to load the full interactive chart for ALGN.

Create Free Account

Setup Quality D 0/7 signals

Score trend

✗ Stage 1 · Basing ✗ Power Trend ✗ RS New High ✗ Trend 4/8 ✗ No Pattern ✗ Gatekeeper Base #1 (A)

See the full conviction stack.

Unlock Insights

Technical Analysis Report Card

$ALGN · $168.05 · as of 2026-07-27 · multi-factor read

/ 100

Strong Sell

Trend · Daily / Weekly / Monthly

Daily ▬ Sideways / consolidating

Weekly ▬ Sideways / consolidating

Monthly ▼ Downtrend

Moving Averages

50-day$172.42 ↓

100-day$174.28 ↓

200-day$165.82 ↑

Bullish (50 > 200)

RSI (14)

Reading42.4 · Bearish

Bearish momentum — sellers in control.

MACD (12/26/9)

StateBearish

Histogram-1.663

Bearish — MACD below its signal line and below zero. Histogram contracting.

Bollinger Bands (20,2)

%B / Width13% · 13.6%

Near the lower band — under pressure or oversold.

Volume · Buyer vs Seller

Up/Down vol0.87 · Neutral

Rel volume1.01×

Balanced — up/down volume is roughly even; no clear hand. Recent volume is easing versus its baseline.

Support & Resistance

R · $174.67swing level

R · $177.66swing level

R · $184.17swing level

Price · $168.05now

S · $167.46swing level

S · $164.61swing level

S · $154.73swing level

Fibonacci · Downtrend swing

23.6%$163.11

38.2% ◄ price here$170.24

50.0%$176.00

61.8%$181.77

78.6%$189.98

Retracement resistance zones measured from the recent swing high down to the low.

The verdict is free. The trade plan is Pro.

Unlock the exact entry, stop-loss, profit target, and reward-to-risk for ALGN — plus the full 495-symbol scanner and Ask-the-Legends chat.

🔒 Start your 7-day free trial →

Monthly downtrendAbove 200-day MA50/200 bullishRS 2 (laggard)

Want this read in a legend's voice? 💬 Ask a Legend about ALGN

Generic technical analysis generated mechanically from price & volume — educational research only, not financial advice or a personalized recommendation. Levels are illustrative; confirm on your own chart. New to these terms? →

Legend Verdicts 6 methodology checks

Who would consider this setup, why it qualifies, and what blocks it — calculated from the same deterministic methodology rules used across Legend AI.

Council consensus: 🟡 3 of 6 legends are Watching — building, not yet a confirmed buy.

Minervini

Avoid

Minervini D

Trend-template read: fails Price > 150-day MA AND 200-day MA.

Passing evidence

1.2 150-day MA > 200-day MAMA150 $173.77 vs MA200 $165.82

1.7 Price within 25% of 52-week high19.3% below 52-week high

Failing evidence

1.1 Price > 150-day MA AND 200-day MAPrice $168.05, MA150 $173.77, MA200 $165.82

1.4 50-day MA > 150-day MA AND 200-day MAMA50 $172.42, MA150 $173.77, MA200 $165.82

2/11 checks

Method → Playbook → Ask →

O'Neil

Avoid

O'Neil D

CANSLIM read: fails C: Quarterly EPS acceleration ≥ 25%.

Passing evidence

S: Base tightness (ATR% ≤ 4.5%)ATR% 3.88%

Failing evidence

C: Quarterly EPS acceleration ≥ 25%-21.6% QoQ

L: RS rank ≥ 80 (IBD leadership)RS rank 2

1/8 checks

Method → Playbook → Ask →

Weinstein

Avoid

Weinstein D

Stage-analysis read: basing (Stage 1) is not an advancing Stage 2.

Passing evidence

Price above 30-week MA (200-day proxy)Price $168.05 vs MA200 $165.82

Not extended from 52-week high (≤ 30% below)19.3% below 52-week high

Failing evidence

Stage 2 (Advancing phase) confirmedStage 1 (Basing)

Volume expansion above averageVolume ratio 1.01x

2/6 checks

Method → Playbook → Ask →

Livermore

Watch

Livermore B

Pivotal-point read: constructive evidence is present, but relative strength is unresolved.

Passing evidence

Price$168.05

Distance from 52-week high19.3% below high

Failing evidence

Relative strengthRS 2

Volume vs average1.01x

3/6 checks

Method → Playbook → Ask →

Darvas

Watch

Darvas B

Box-theory read: constructive evidence is present, but relative strength is unresolved.

Passing evidence

Price$168.05

Distance from 52-week high19.3% below high

Failing evidence

Relative strengthRS 2

Volume vs average1.01x

3/6 checks

Method → Playbook → Ask →

Wyckoff

Watch

Wyckoff B

Supply-and-demand read: constructive evidence is present, but relative strength is unresolved.

Passing evidence

Price$168.05

Distance from 52-week high19.3% below high

Failing evidence

Relative strengthRS 2

Volume vs average1.01x

3/6 checks

Method → Playbook → Ask →

Breakout Health

No active breakout tracked — Legend AI monitors daily for pivot-point breaks. What's a breakout?

Unlock Follow-Through Tracking

RS Line vs SPY 52-week relative strength · blue = RS line · dashed = MA50 · dot = NH ▼ Falling

Accumulation / Distribution last 65 sessions · green = acc on high vol · red = dist on high vol Net -5 B

Minervini · Grade Card

Fundamentals & leadership quality — Minervini SEPA criteria · 2/7 met

C 2/7 SEPA

Separate score from the 8-point Trend Template (4/8): the Trend Template grades the price structure, this grades the company & leadership (earnings, sales, margins, RS rank). A stock can ride a clean trend while its fundamentals lag, so the two often differ by design — they are not the same checklist.

✗ EPS acceleration ≥25% QoQ -22%

✗ Revenue growth ≥20% YoY +1%

✓ Gross margin ≥30% 69%

✗ ROE ≥17% 11%

✗ RS rating ≥80 (leadership) 2

✗ Stage 2 uptrend (Weinstein) Stage 1

✓ Within 25% of 52W high -19.3%

Method Playbook

📋 Trade it like Weinstein EXACT LEVELS · PRO

Minervini O'Neil Livermore Weinstein Darvas Wyckoff

Weinstein D · Avoid — The deterministic methodology check is Avoid; wait until the blocking criteria are resolved.

Pivot

Pro level

Published-method rule: Use Stage 1 resistance and the rising 30-week moving average as the Stage 2 transition boundary.
Evidence: Canonical setup geometry is available with Pro.

Entry trigger

Pro level

Published-method rule: Require a Stage 2 breakout above resistance on expanding volume; avoid entries while the 30-week average is flat or falling.
Evidence: Canonical setup geometry is available with Pro.

Initial stop

Pro level

Published-method rule: Start below the breakout structure or Stage 1 support where a return to the base invalidates the Stage 2 transition.
Evidence: Canonical setup geometry is available with Pro.

Trail

Rule-based

Published-method rule: Trail beneath rising 30-week support or later higher swing lows while Stage 2 remains intact.
Evidence: Planned management rule; no stored stop or broker order is changed automatically.

Exit / invalidation

Pro level

Published-method rule: Exit on a decisive 30-week support failure or a Stage 3/Stage 4 transition; never treat a failed Stage 2 break as healthy consolidation.
Evidence: Canonical setup geometry is available with Pro.

Deterministic educational plan, not a recommendation. No order or stop is changed automatically. Method and sources →

The published-method workflow is public. Unlock exact pivot, entry, stop, target, and sizing with Pro →

Forming Patterns (predictive — not confirmed)

Inverse Head & Shoulders bullish forming

80% built

Possible inverse head & shoulders — not confirmed. Watch for a daily close above ~189.57 (neckline) to confirm, with a measured move toward ~227.57. A drop under the right shoulder near 165.50 weakens the structure; a close below the head near 151.58 invalidates it.

Confirms above 189.57

Invalidates at 151.58

Left Shoulder 167.46

Head 151.58

Right Shoulder 165.50

Neckline 189.57

Target 227.57

LS 167.46 / head 151.58 / RS 165.50, neckline ~189.57, 11.4% below confirmation

Predictive pattern recognition is educational — most forming structures never confirm. Wait for the confirmation level before treating this as a setup.

Pattern Analysis

watchlist_candidate

0.0 score

RS Score 2

Trend 4/8 ✗

Why This Setup?

watchlist_candidate

Near-miss 4/8 — needs: price above sma150 200, sma50 above sma150 200, price above sma50, rs score above 70

The Universal Edge Check

The panel is uneasy

Too many universals unmet — this leans closer to a guess than a trade.

0/7 universals met

In a confirmed uptrend Trend 4/8 — not yet Stage 2
Risk is defined No stop — undefined risk
Asymmetric reward No target set
Not chasing (in range) Pivot distance unknown
Volume confirms 1.0× average — light
Clear of earnings in 1 days — event risk
A relative-strength leader RS 1 — laggard

Why these seven? → The Universal Edge

Minervini Trend Template

4/8

Grades the price structure — moving-average stacking, distance from the 52-week high/low, and relative strength above the ≥70 uptrend bar. This is the technical trend check; the company's fundamentals and ≥80 RS leadership are scored separately in the Grade Card.

Price above SMA 150 & 200 $168.05 vs SMA150 $173.77 / SMA200 $165.82

SMA 150 above SMA 200 SMA150 $173.77 vs SMA200 $165.82

SMA 200 trending up Slope +4.70 over 20 days

SMA 50 above SMA 150 & 200 SMA50 $172.42

Price above SMA 50 $168.05 vs SMA50 $172.42

30%+ above 52W low +37.7% from $122.00

Within 25% of 52W high -19.3% from $208.30

RS score above 70 RS 2

Fundamentals

52W Range

53%

Mkt Cap SEC

12.0B

EPS QoQ

-22%

Rev YoY

+1%

ROE

11%

Gross Margin

69%

D/E

0.00

EPS TTM

$5.65

P/E TTM

29.7x

Float

72M

Insider

No Buy

Company

Legend AI snapshot

Align Technology, Inc.

ALGN · NASDAQ · Health Technology · Medical Specialties

$168.05latest close $12.0Bmarket cap 1RS rank 0setup score

Scan History

4× streak

Jul 28

watchlist_candidate

Jul 23

watchlist_candidate

0 -0.1%

Jul 22

Trend Only ✓ Gate

47 -2.6%

Jul 22

Trend Only ✓ Gate

47 -2.6%

Jul 21

Darvas Box ✓ Gate

49 -5.3%

Get the full picture on ALGN

Pro members see entry/stop/target levels, R:R ratios, intraday alerts, and every setup detected across 495+ symbols daily.

Start 7-Day Free Trial